Literature DB >> 30511787

Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA.

Jørn Eivind Tungen1, Lisa Gerstmann1,2, Anders Vik1, Roberta De Matteis3, Romain Alexandre Colas3, Jesmond Dalli3, Nan Chiang4, Charles Nicholas Serhan4, Markus Kalesse2, Trond Vidar Hansen1.   

Abstract

New drugs that can resolve inflammation without immunosuppressive effects are at the medicinal chemistry frontier. Pro-resolving endogenously formed small molecules, that is, the resolvins, are excellent candidates displaying such bioactions. The first total synthesis of the specialized pro-resolving mediator RvD1n-3 DPA has been achieved using the underutilized sp3 -sp3 Negishi cross coupling reaction and an alkyne hydrosilylation-protodesilylation protocol. Biological evaluations revealed that this novel mediator displays low nanomolar pro-resolving properties and potently activates the human DRV1/GPR32 receptor. As such, this endogenous natural product is a lead compound for the development of novel immunoresolvents.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Karstedt's catalyst; natural products; sp3-sp3 cross-coupling; specialized pro-resolving mediators; total synthesis

Mesh:

Substances:

Year:  2018        PMID: 30511787      PMCID: PMC6368681          DOI: 10.1002/chem.201806029

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  39 in total

Review 1.  Resolvins and protectins in the termination program of acute inflammation.

Authors:  Amiram Ariel; Charles N Serhan
Journal:  Trends Immunol       Date:  2007-03-06       Impact factor: 16.687

2.  Resolvin E1 and protectin D1 activate inflammation-resolution programmes.

Authors:  Jan M Schwab; Nan Chiang; Makoto Arita; Charles N Serhan
Journal:  Nature       Date:  2007-06-14       Impact factor: 49.962

3.  The first Negishi cross-coupling reaction of two alkyl centers utilizing a Pd-N-heterocyclic carbene (NHC) catalyst.

Authors:  Niloufar Hadei; Eric Assen B Kantchev; Christopher J O'Brien; Michael G Organ
Journal:  Org Lett       Date:  2005-08-18       Impact factor: 6.005

4.  Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.

Authors:  Yee-Ping Sun; Sungwhan F Oh; Jasim Uddin; Rong Yang; Katherine Gotlinger; Eric Campbell; Sean P Colgan; Nicos A Petasis; Charles N Serhan
Journal:  J Biol Chem       Date:  2007-01-23       Impact factor: 5.157

5.  The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering.

Authors:  Amiram Ariel; Pin-Lan Li; Wei Wang; Wang-Xian Tang; Gabrielle Fredman; Song Hong; Katherine H Gotlinger; Charles N Serhan
Journal:  J Biol Chem       Date:  2005-10-10       Impact factor: 5.157

6.  Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.

Authors:  Charles N Serhan; Katherine Gotlinger; Song Hong; Yan Lu; Jeffrey Siegelman; Tamara Baer; Rong Yang; Sean P Colgan; Nicos A Petasis
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

7.  Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation.

Authors:  Song Hong; Karsten Gronert; Pallavi R Devchand; Rose-Laure Moussignac; Charles N Serhan
Journal:  J Biol Chem       Date:  2003-02-17       Impact factor: 5.157

8.  Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress.

Authors:  Pranab K Mukherjee; Victor L Marcheselli; Charles N Serhan; Nicolas G Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-19       Impact factor: 11.205

9.  Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.

Authors:  Charles N Serhan; Rong Yang; Kimberly Martinod; Kie Kasuga; Padmini S Pillai; Timothy F Porter; Sungwhan F Oh; Matthew Spite
Journal:  J Exp Med       Date:  2008-12-22       Impact factor: 14.307

10.  Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

Authors:  Charles N Serhan; Song Hong; Karsten Gronert; Sean P Colgan; Pallavi R Devchand; Gudrun Mirick; Rose-Laure Moussignac
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more
  7 in total

Review 1.  Neutrophil Signaling That Challenges Dogmata of G Protein-Coupled Receptor Regulated Functions.

Authors:  Claes Dahlgren; André Holdfeldt; Simon Lind; Jonas Mårtensson; Michael Gabl; Lena Björkman; Martina Sundqvist; Huamei Forsman
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-11

2.  Stereoselective Synthesis and Structural Confirmation of the Specialized Pro-Resolving Mediator Resolvin E4.

Authors:  Amalie Føreid Reinertsen; Karoline Gangestad Primdahl; Ashley Elizabeth Shay; Charles Nicholas Serhan; Trond Vidar Hansen; Marius Aursnes
Journal:  J Org Chem       Date:  2021-02-03       Impact factor: 4.354

3.  Stereoselective synthesis of MaR2n-3 DPA.

Authors:  Jeanne Sønderskov; Jørn E Tungen; Francesco Palmas; Jesmond Dalli; Charles N Serhan; Yngve Stenstrøm; Trond Vidar Hansen
Journal:  Tetrahedron Lett       Date:  2019-12-09       Impact factor: 2.415

4.  Stereoselective Synthesis, Configurational Assignment and Biological Evaluations of the Lipid Mediator RvD2n-3 DPA.

Authors:  Amalie F Reinertsen; Karoline G Primdahl; Roberta De Matteis; Jesmond Dalli; Trond V Hansen
Journal:  Chemistry       Date:  2021-12-28       Impact factor: 5.020

5.  Expression and function of resolvin RvD1n-3 DPA receptors in oral epithelial cells.

Authors:  Maria G Balta; Olav Schreurs; Trond V Hansen; Jørn E Tungen; Anders Vik; Enrico Glaab; Thomas M Küntziger; Karl Schenck; Espen S Baekkevold; Inger Johanne S Blix
Journal:  Eur J Oral Sci       Date:  2022-07-08       Impact factor: 2.160

6.  The First Total Synthesis of the Lipid Mediator PD2n-3 DPA.

Authors:  Jørn Eivind Tungen; Karoline Gangestad Primdahl; Trond Vidar Hansen
Journal:  J Nat Prod       Date:  2020-06-16       Impact factor: 4.050

7.  Synthesis, Structural Confirmation, and Biosynthesis of 22-OH-PD1n-3 DPA.

Authors:  Jannicke Irina Nesman; Karoline Gangestad Primdahl; Jørn Eivind Tungen; Fransesco Palmas; Jesmond Dalli; Trond Vidar Hansen
Journal:  Molecules       Date:  2019-09-05       Impact factor: 4.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.